First Time Loading...

Aligos Therapeutics Inc
NASDAQ:ALGS

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
NASDAQ:ALGS
Watchlist
Price: 0.846 USD 9.87% Market Closed
Updated: May 4, 2024

Wall Street
Price Targets

ALGS Price Targets Summary
Aligos Therapeutics Inc

Wall Street analysts forecast ALGS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALGS is 4.08 USD with a low forecast of 1.01 USD and a high forecast of 7.35 USD.

Lowest
Price Target
1.01 USD
19% Upside
Average
Price Target
4.08 USD
382% Upside
Highest
Price Target
7.35 USD
769% Upside
Aligos Therapeutics Inc Competitors:
Price Targets
300639
Guangdong Hybribio Biotech Co Ltd
540% Upside
IOVA
Iovance Biotherapeutics Inc
96% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside
PHIL
Philogen SpA
34% Upside
VIR
Vir Biotechnology Inc
216% Upside
042520
Hans Biomed Corp
175% Upside
4893
Noile-Immune Biotech Inc
184% Upside
TIL
Instil Bio Inc
151% Upside

Revenue
Forecast

Revenue Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALGS's stock price target?
Price Target
4.08 USD

According to Wall Street analysts, the average 1-year price target for ALGS is 4.08 USD with a low forecast of 1.01 USD and a high forecast of 7.35 USD.